Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses  by Igyártó, Botond Z. et al.
Immunity
ArticleSkin-Resident Murine Dendritic Cell Subsets
Promote Distinct and Opposing Antigen-Specific
T Helper Cell Responses
Botond Z. Igya´rto´,1 Krystal Haley,1 Daniela Ortner,1 Aleh Bobr,1 Maryam Gerami-Nejad,2 Brian T. Edelson,5
Sandra M. Zurawski,3 Bernard Malissen,4 Gerard Zurawski,3 Judith Berman,2 and Daniel H. Kaplan1,*
1Department of Dermatology, Center for Immunology
2Department of Molecular and Cellular Biology
University of Minnesota, Minneapolis, MN 55455, USA
3Baylor Institute for Immunology Research and INSERM U899 - ANRS Center for Human Vaccines, Dallas, TX 75204, USA
4Centre d’Immunologie de Marseille-Luminy, Universite´ de la Me´diterrane´e, Case 906, 13288 Marseille Cedex 9, France
5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
*Correspondence: dankaplan@umn.edu
DOI 10.1016/j.immuni.2011.06.005SUMMARY
Skin-resident dendritic cells (DCs) arewell positioned
to encounter cutaneous pathogens and are required
for the initiation of adaptive immune responses.
There are at least three subsets of skin DC— Langer-
hans cells (LC), Langerin+ dermal DCs (dDCs), and
classic dDCs. Whether these subsets have distinct
or redundant function in vivo is poorly understood.
Using a Candida albicans skin infection model, we
have shown that direct presentation of antigen by
LC is necessary and sufficient for the generation of
antigen-specific T helper-17 (Th17) cells but not for
the generation of cytotoxic lymphocytes (CTLs). In
contrast, Langerin+ dDCs are required for the gener-
ation of antigen specific CTL and Th1 cells. Langerin+
dDCs also inhibited the ability of LCs and classic DCs
to promote Th17 cell responses. This work demon-
strates that skin-resident DC subsets promote
distinct and opposing antigen-specific responses.
INTRODUCTION
Dendritic cells (DCs) in the periphery are specialized tissue-resi-
dent antigen-presenting cells that acquire exogenous antigen via
multiple routes (Banchereau et al., 2000). In response to path-
ogen products, they become activated and migrate to regional
lymph nodes where they present processed antigen acquired
in the periphery to CD4+ T helper (Th) cells and CD8+ cytotoxic
T lymphocytes (CTLs), thereby initiating adaptive immune
responses (Banchereau et al., 2000; Itano et al., 2003). Recently,
it has been demonstrated that only certain DC subsets have the
ability to cross-present exogenous antigen to CTLs (Bedoui
et al., 2009; Dudziak et al., 2007; Henri et al., 2010; Hildner
et al., 2008). In contrast, most DC subsets appear to be capable
of presenting antigen to CD4+ T cells, and the Th cell phenotype
that develops is largely determined by the adjuvant to which the
DC is exposed (Joffre et al., 2010; Manicassamy and Pulendran,
2009; Reis e Sousa, 2004).260 Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc.In uninflamed skin, three subsets of resident DCs can be
distinguished on the basis of anatomical location and cell
surface expression of the proteins Langerin and CD103 (Kaplan,
2010). Langerhans cells (Langerin+ CD103) reside in the
epidermis where they form a self-renewing population that has
an ontogeny distinct from other DCs (Chorro and Geissmann,
2010; Ginhoux and Merad, 2010). In the dermis, DC subsets
can be segregated into the well-defined Langerin+ CD103+
dermal DC (dDC) subset and a more heterogeneous Langerin
CD103 dDC subset that can be further subdivided with addi-
tional markers (Henri et al., 2010).
Contact hypersensitivity (CHS) to epicutaneous application of
haptens is the classic assay to evaluate adaptive cutaneous
immune responses. Examining CHS responses in mice lacking
DC subsets is a commonly employed technique to determine
the functional significance of skin DC subsets but the results
have beenmixed (Kaplan, 2010). Murine Langerin-diptheria toxin
receptor (MuLangerin-DTR) mice lack LCs and Langerin+ dDCs
shortly after administration of diphtheria toxin (DT). Langerin+
dDCs repopulate the skin more quickly than LCs so that
7–14 days after DT administration Langerin+ dDC are largely
intact while LCs remain absent (Bursch et al., 2007). CHS is
reduced in mice sensitized shortly after DT administration but
returns to normal when sensitization is delayed so that only
LCs are absent. This suggests that Langerin+ dDCs but not
LCs are required for CHS. However, other studies using the
same system with low doses of hapten or chimeric mice
concluded that LC and Langerin+ dDC have redundant functions
(Honda et al., 2010; Noordegraaf et al., 2010). In contrast, CHS
responses to multiple haptens are increased in transgenic
mice that use the human langerin promoter to express either
attenuated Diphtheria toxin subunit A (huLangerin-DTA) or
the primate Diptheria toxin receptor (huLangerin-DTR) to specif-
ically ablate LCs constitutively or inducibly (Bobr et al., 2010;
Igyarto et al., 2009; Kaplan et al., 2005). Finally, Batf3/ mice
that lack Langerin+ dDCs but not LCs develop normal CHS
responses (Edelson et al., 2010).
LC-like cells derived in vitro from bone marrow precursors can
efficiently cross-present soluble antigen to CD8+ CTLs (Klechev-
sky et al., 2008). Similarly, LCs isolated ex vivo from human and
mouse skin can also cross-present antigenwhen cultured in vitro
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Langerin+ dDCs isolated ex vivo from lymph nodes of mice after
herpes simplex skin infection or from mice engineered to
express ovalbumin in the epidermis are the only DC subset
capable of efficiently cross-presenting antigen (Bedoui et al.,
2009; Henri et al., 2010). Unfortunately, studies examining
cross-presentation in vivo have relied on muLangerin-DTR
mice or delivery of antigen to DC with antibody-antigen conju-
gates that cannot distinguish Langerin+ dDCs from LCs (Idoyaga
et al., 2008; Stoitzner et al., 2006). Hence, it is unresolved which
DC subset(s) cross-presents skin-derived antigen in vivo. In
addition, the contribution made to CD4+ Th cell differentiation
by individual skin-resident DC subsets has not been explored.
Thus, the basic question of whether skin resident DCs have
unique or redundant functions in vivo remains unresolved.
A major obstacle that has hampered the detailed analysis
of skin DC function in vivo is the absence of a model in
which antigen can be delivered to the skin that employs a phys-
iologic adjuvant, allows for the examination of antigen-specific
responses, but does not bypass the epidermis. Antigen-specific
responses are difficult to examine in CHS (Igyarto et al., 2009). In
addition, haptens have poorly defined adjuvant properties and
small differences in technique lead to variable results (Kaplan,
2010). Epicutaneous protein immunizations also have poorly
defined adjuvants and variable results depending on the
anatomic site of immunization (Wang et al., 2008). Finally, estab-
lished skin infection models require either dermal injection of
pathogens (e.g., Leishmania) (Ritter et al., 2004) or severe skin
wounding (e.g., Staphylococcus) (Miller et al., 2006) or can infect
and kill LCs (e.g., HSV) (Cunningham et al., 2010).
Candida albicans is a commensal organism of mucosal sites in
humans and also a pathogen that infects the vagina, oropharynx,
and skin. Opportunistic systemic infections in immunocompro-
mised patients is associated with a high mortality (Gudlaugsson
et al., 2003; Wisplinghoff et al., 2004). In humans, Th17 CD4+
T cells are an important component of the anti-Candida immune
response. C. albicans-specific memory T cells are largely Th17
cells (Acosta-Rodriguez et al., 2007). In addition, patients with
hyper IgE syndrome and autoimmune polyendocrinopathy-
candidiasis-ectodermal dystrophy (APECED) syndrome develop
severe mucocutaneous candidiasis and have defects that inhibit
Th17 cell responses (Kisand et al., 2010; Ma et al., 2008). Mean-
while in mice, the secretion of interleukin-17 (IL-17) and Th17
cells are essential for host defense against Candida (Conti
et al., 2009; Kagami et al., 2010; Lin et al., 2009).
In this study, we have engineered recombinant C. albicans to
express multiple well-defined T cell antigens and developed
a model of C. albicans skin infection that does not bypass the
epidermis. By combining these tools with mice lacking specific
skin DC subsets and examining antigen-specific responses
in vivo, we have been able to delineate nonredundant functions
for skin-resident DC subsets.
RESULTS
Cutaneous Candidiasis Model
We adapted the techniques described by (Sohnle and Hahn
(1989) and Gaspari et al. (1998) to generate a protocol to reliably
infect the skin of mice with C. albicans. Back hair was removedby shaving and chemical depilation followed by disruption of
the stratum corneum with sandpaper. The procedure was cali-
brated to remove 50% of the stratum corneum while leaving
the epidermis intact as assayed by hematoxylin stained sections
(unpublished data). C. albicans blastoconidia of the standard
laboratory strain SC5314 (henceforth termed Calb-WT) was
then inoculated onto the site. Within 48 hr, there was clear
evidence of infection on the basis of the presence of erosions,
erythema, and adherent crust (unpublished data). Histologic
evaluation of the skin at this time point revealed numerous foci
of yeast adherent the outer epidermis with filamentous forms
(indicated by arrowheads) invading through the epidermis and
into the dermis (Figure 1A). Importantly, filaments were seen
penetrating through intact epidermis. The lesions began to
resolve by day +4 and neither yeast or filaments could be found
by histologic examination of the skin by day +7 (unpublished
data).
Wild-type (WT) mice and mice with a constitutive absence of
LC (huLangerin-DTA, see Table 1) developed lesions with
a similar appearance and histology. We compared the number
of invasive C. albicans in each strain by culturing skin from
infected mice that had been cleansed with povidone-iodine to
remove noninvasive C. albicans. Both strains of mice harbored
similar numbers of invasive C. albicans that peaked on day +2
after infection and became undetectable on day +7 (Figure 1B).
Thus, superficial infection with C. albicans produced a transient
infection that was not altered by the absence of LC.
To determine whether an adaptive immune response against
Candida developed after infection andwhether LCs participated,
we infected WT, Rag1/ and huLangerin-DTA mice. Specific
delayed type hypersensitivity (DTH) responses in footpads
challenged with heat killed C. albicans were examined 7 days
later (Figure 1C). WT mice developed a robust DTH response
that was significantly greater than Rag1/ mice in which the
response was barely detectable. Langerin-DTA mice, however,
developed a greatly exaggerated DTH response that was two
to three times greater than WT mice. Importantly, dermal injec-
tion of C. albicans that bypassed the epidermis did not produce
exaggerated responses in huLangerin-DTA mice. Thus, a super-
ficial skin infection withC. albicans generated a specific adaptive
immune response that was exaggerated in the absence of LC.
This was completely consistent with our prior work with CHS
and demonstrated that this was an ideal system with which to
compare the function of LC and dermal DC.
Generation of Recombinant C. albicans
We constructed a recombinant C. albicans strain by modifying
an existing plasmid (pMG2120) (Selmecki et al., 2008), which
encodes green fluorescent protein (GFP), the ADH1ter transcrip-
tion termination sequence, and the Nat1 selectable marker.
We then fused the Eno1 promoter and complete Eno1 coding
sequence, in frame, to the N-terminus of GFP. Next, we
inserted synthetic oligonucleotides encoding the well-character-
ized immunodominant T cell epitopes, OVA323-339, OVA257-264,
I-Ea50-66, and 2W1S (Moon et al., 2007) in frame with the
C terminus of GFP (Figure 2A) so that the ADH1ter transcription
termination sequence and the Nat1 selectable marker are 30 to
the T cell epitopes (Shen et al., 2005). The fusion construct
was transformed into C. albicans wild-type strain SC5314.Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc. 261
Figure 1. C. albicans Skin Infection Model
The skin of wild-type mice was infected with
2 3 108 blastoconidia of the SC5314 strain of
C. albicans.
(A) Skin from infected mice harvested on day +2
after infection was sectioned and stainedwith PAS
to highlight fungi. Numerous yeast forms are
evident on the external surface of the skin. Fila-
mentous forms (arrow heads) can be observed
penetrating through the epidermis into the dermis.
Representative images are shown. The scale bar
represents 50mm.
(B) Skin samples from cohorts of WT (solid line,
n = 8) and huLangerin-DTA (broken line, n = 8)
mice were cleaned with provine-iodine prior to
being harvested at the indicated time after infec-
tion. C. albicans CFU is expressed as colonies per
mg of tissue.
(C) WT, Rag1/, and huLangerin-DTA mice were
infected on the skin or by intradermal injection of
107 blastoconidia. DTH responses on day +7 were
measured by specific footpad swelling 24 hr after
injection of 107 heat killed C. albicans. Data is
representative of 3 independent experiments with
cohorts of at least 6 mice per group. *p < 0.05.
Table 1. Comparison of the Skin DC Subsets Ablated in
DC-Deficient Mice
Mice LCs Langerin+ dDCs Langerin dDCs
WT + + +
huLangerin-DTA  + +
Batf3/ +  +
muLangerin-DTR   +
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identified by GFP fluorescence (Figures 2B and 2C). Successful
homologous recombination at the Eno1 locus was verified by
PCR (unpublished data).
To confirm successful expression and availability of the
T cell epitopes, we cultured Calb-WT (shaded line) and Calb-
Ag (solid line) with antigen presenting cells (APC) and carboxy-
fluorescein diacetate succinimidyl ester (CFSE)-labeled CD8+
T cells from OT-I mice specific for OVA257-264 and CD4
+ T cells
from OT-II mice specific for OVA323-339 (Figures 2D and 2E).
The parental Calb-WT strain did not promote proliferation,
whereas Calb-Ag induced robust OT-I and OT-II proliferation.
Thus, the GFP-antigen fusion protein is highly expressed and
available for processing and presentation to both CD4+ and
CD8+ T cells.
Cross-presentation of Antigen In Vivo
To determine whether LC participate in cross-presentation of
antigen to CTL in vivo, we adoptively transferred into WT and
Langerin-DTA mice CFSE-labeled CD90.1 congenic, CD44low
naive, OT-I cells isolated from OT-I TCR transgenic mice. The
mice were then infected on their skin with either Calb-WT or
Calb-Ag and the degree of proliferation was assessed in skin-
draining lymph nodes 4 days later. As expected, OT-I did not
proliferate in mice infected with Calb-WT (Neg) but did in mice
infected with Calb-Ag (Figures 3A and 3B). There was, however,
no difference in the degree of proliferation or total number of
OT-I cells between WT and huLangerin-DTA mice. In addition,
expression of granzyme B and IFN-g, markers of CTL activation,
were similar in both strains of mice (Figure S1). Thus, LCs are not
required for cross-presentation of antigen in vivo.
Batf3/mice and muLangerin-DTRmice treated with DT lack
Langerin+ dDC (Table 1). As expected, OT-I proliferation in both262 Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc.lines was significantly reduced compared with WT mice,
although a small amount of OT-I proliferation, 2-fold greater
than uninfected mice, was observed (Figures 3A and 3B).
Although CD8+ DCs are also absent from Batf3/ and reduced
in muLangerin-DTR mice, these cells did not acquire antigen in
our skin-Infection model and are unlikely to participate in the
response (unpublished data). Thus, Langerin+ dDC are required
for optimal cross-presentation in vivo, but another cell type can
inefficiently cross-present cutaneous antigen in the absence of
this DC subset.
Antigen Presentation by LC Is Necessary for Th17 Cell
Development
To examine whether LC can present antigen to CD4+ T cells, we
adoptively transferred CFSE-labeled, CD90.1 congenic CD4+
T cells isolated from TEa transgenic mice that had been main-
tained on a Rag1/ background into WT and huLangerin-DTA
mice. Mice were infected and the degree of proliferation was
assessed. We consistently observed slightly more CFSE dilution
and greater total numbers of TEa cells in WT mice (13-fold
expansion) than huLangerin-DTA mice (8-fold expansion)
(Figures 4A and 4B). Experiments using CD4+ T cells isolated
from OT-II mice produced similar results (unpublished data).
Figure 2. Generation of Recombinant
C. albicans
In (A), EGFP and the model T cell antigens, 2W1S,
OVA323-339, OVA257-264, and I-Ea50-66 were in-
serted in frame into the genome of C. albicans
(Calb-Ag) (SC5314) at the C terminus of the
enolase gene. Expression GFP was confirmed by
(B) direct visualization fluorescence of Calb-Ag
blastoconidia and by (C) flow cytometry com-
paring Calb-Ag (solid line) with Calb-WT (shaded).
For confirming expression and availability of the
T cell epitopes, Calb-WT (shaded) and Calb-Ag
(solid line) were cultured with irradiated spleen
cells and with CFSE-labeled CD90.1 congenic
OT-I (D) or OT-II (E) cells. The amount of CFSE on
CD90.1 gated cells T cells is shown after 3 days in
culture. Data are representative of three indepen-
dent experiments.
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expanded during infection. Calb-Ag infection produced a mix
of Th1 cells producing IFN-g and Th17 cells producing IL-17A,
IL-17F, and IL-22 in WT mice (Figures 4C and 4D). All Th17 cells
coexpressed IL-22 but not IFN-g (Figure S2). Surprisingly, the
number of cells producing IL-17A, IL-17F, and IL-22was dramat-
ically reduced in the absence of LC (Figure 4D). In contrast, the
number of cells producing IFN-g was only slightly reduced in
huLangerin-DTA mice and did not achieve statistical signifi-
cance. We did not observe significant expression of IL-4, IL-
10, IL-13, or Foxp3 (unpublished data). Thus, the absence of
LC has a profound effect on the development of Th17 cells.
To determine whether direct presentation by LC is required for
Th17 cell development, we performed similar experiments in
huLangerin-Cre x I-Ab-flox mice. Cre recombinase is constitu-
tively expressed by LC in Langerin-Cre mice (Kaplan et al.,
2007). Like the huLangerin-DTA mice, cells other than LCs
are not affected. Thus, huLangerin-Cre on an I-Ab-flox back-
ground have a constitutive and durable absence of major histo-
compatibility complex class II (MHC-II) limited to LCs (Igyarto
et al., 2009). As was observed with huLangerin-DTA mice, the
absence of MHC-II on LCs led to reduced proliferation of TEa
cells and a near-complete absence of Th17 cells (Figure 5).
Thus, direct presentation of antigen by LC is required for the
development of a Th17 but not a Th1 cell response.
Antigen Presentation by LC Is Sufficient for Th17 Cell
Development
In order to limit antigen presentation to LCs, we sought to target
antigen to LCs by using Langerin antibodies that have been
associated with antigen. Published efforts using this technique
have used antibodies to mouse Langerin that target several DC
subsets in addition to LCs (Idoyaga et al., 2008). To overcome
this problem, we generated a monoclonal antibody (2G3) that
is specific for the ectodomain of human Langerin and that
does not cross react with murine Langerin (Figure S3). Thus,
introduction of 2G3-antigen complexes into transgenic mice
expressing huLangerin will selectively target antigen to LCs.
HuLangerin-DTR transgenic mice express human Langerin
and the diphtheria toxin receptor exclusively on LCs (Bobr
et al., 2010). HuLangerin-DTR mice that had not been treated
with DT were injected intraperitoneally (i.p.) with anti-huLangerin(2G3) conjugated to Alexa-647. As expected, LCs isolated from
the epidermis had efficiently acquired the antibody (Figure 6A).
Keratinocytes, dendritic epidermal T cells (DETCs), and LCs
from WT mice did not acquire the antibody. Similarly, in lymph
node, 2G3 could only be detected in LCs from huLangerin-DTR
mice and not in LCs fromWTmice, Langerin+ dDCs, or Langerin-
dDCs (Figure 6C). All other cells, including B cells and macro-
phages, in both lymph node and spleen did not acquire 2G3
(unpublished data). Immunofluorescence of LC isolated from
the epidermis showed that 2G3 (red) colocalized with the
endogenous mouse Langerin (green) (Figure 6B). Thus, 2G3 effi-
ciently binds to LCs in vivo and localizes to the same subcellular
compartments as the endogenous muLangerin, suggesting that
it should enter the endocytic processing pathway.
We generated recombinant 2G3 with the peptide sequences
for OVA257-264, I-Ea50-66 or 2W1S (for which an efficient MHC-II
tetramer is available) fused to the C terminus (Moon et al.,
2007). To test the ability of LC to cross-present antigen during
infection with C. albicans, we injected OT-I adoptively trans-
ferred mice i.p. with 2G3-OVA257-264. Mice were then infected
with Calb-WT for LC activation. The only source of antigen was
2G3-OVA257-264. OT-I did not proliferate in WT or huLangerin-
DTR mice (Figure 6D). However, OT-I did proliferate in response
to subcutaneous (s.c.) immunization with 2G3-OVA257-264 in
complete Freund’s adjuvant (CFA), thereby demonstrating that
OVA257-264 was present. In contrast to OT-I, analogous experi-
ments with TEa cells and 2G3-I-Ea50-66 showed a robust CD4
+
T cell expansion in C. albicans-infected mice (Figure 6e). Activa-
tion of LCs with either C. albicans or the common skin pathogen,
Staphylococcus aureus, resulted in expression of IL-17A (Fig-
ure 6f). We also observed that endogenous 2W1S-specific
CD4+ T cells expanded and expressed IL-17A in C. albicans-
infected huLangerin-DTR mice injected with 2G3-2W1S (Fig-
ure S4). Thus, antigen presentation by LC during skin infection
with C. albicans or S. aureus is sufficient for driving proliferation
of CD4 T cells and differentiation of Th17 cells but not for cross-
priming of CTL.
Langerin+ dDCs Promote Th1 and Inhibit Th17 Cell
Differentiation
IL-1b, IL-6, and transforming growth factor b (TGF-b) participate
in the initial development of Th17 cells, and IL-23 maintains theirImmunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc. 263
Figure 3. LCs Are Not Required for Antigen
Cross-presentation In Vivo
(A) A total of 3 3 105 CFSE-labeled, CD90.1,
CD44lo OT-I cells (CTL specific for OVA257-264)
were adoptively transferred into WT, huLangerin-
DTA (top panel), Batf3/ (middle panel), or
muLangerin-DTR (bottom panel) mice. Mice were
infected on their skin with either Calb-WT (Neg) or
Calb-Ag. Skin-draining LNswere harvested 4 days
later. CFSE and expression of CD44 are shown on
CD8+, CD90.1+ gated cells. Numbers adjacent to
outlined areas are the percentage of cells that
have diluted CFSE.
(B) Total numbers of CD90.1+, OT-I cells recov-
ered from each strain are shown. Each symbol
represents an individual animal. WT and
huLangerin-DTA are not significantly different.
Batf3/ and DT-treated muLangerin-DTR mice
are not significantly different from one another, but
are significantly less thanWT and huLangerin-DTA
mice (p < 0.0001). n.s., not significant. See also
Figure S1.
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LC-mediated induction of Th17 cells, we compared cytokine
expression in LC sorted from lymph nodes of naive and infected
mice (Figure 7A and Figure S5A). LC increased expression of264 Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc.IL-1b (6-fold) and IL-6 (8-fold) in
response to infection, but TGF-b and
IL-23 remained unchanged. IL-12 could
not be reliably detected. We next com-
pared expression of IL-1b, IL-6, TGF-b,
and the regulated chains of the IL-12
family members IL-12(p35), IL-23(p19),
and IL-27(p28) between LC, Langerin+
dDCs and Langerin- dDCs sorted from
lymph node (LN) after skin infection with
C. albicans. Langerin+ dDCs produced
significantly less IL-1b and IL-6 than
LCs (Figure 7B and Figure S5A). We
also observed that Langerin+ dDCs but
not LCs expressed message for IL-12.
Interestingly, Langerin+ dDCs expressed
higher amounts of IL-27, which has
been demonstrated to suppress Th17
cell development (Stumhofer et al.,
2010). Similar patterns of expression
were observed after skin infection with
S. aureus (Figure S5B). This pattern of
cytokine expression is certainly consis-
tent with our observations that LCs
promote Th17 cells. However, it also
raises the possibility that Langerin+ dDC
could promote Th1 and simultaneously
inhibit Th17 cell responses.
To test this hypothesis, we infectedWT
and Batf3/ mice (Table 1) with Calb-Ag
and analyzed the phenotype of TEa cells.
The absence of Langerin+ dDCs did not
alter proliferation based on CFSE dilution(Figure 7C) or total numbers of TEa cells (Figure S6A). IFN-g-
producing cells did not develop in Batf3/ mice and the
numbers of cells expressing Th17-associated cytokines was in-
creased 2-fold (Figure 7D). Thus, Langerin+ dDCs are required
Figure 4. LCs Are Necessary for Th17 Cell Development
(A) A total of 33 105 CFSE-labeled, CD90.1 TEa cells (CD4+ T cells specific for I-Ea50-66) were transferred into WT and huLangerin-DTAmice. Mice were infected
on their skin with either Calb-WT (Neg) or Calb-Ag. Skin-draining LNs were harvested 4 days later. CFSE and expression of CD44 are shown on CD4+, CD90.1+
gated cells.
(B) Total numbers of CD90.1+, TEa cells recovered from each strain are shown. Each symbol represents an individual animal.
(C) As in (A), except that cells were restimulated in vitro with PMA-ionomycin prior to intracellular staining with the indicated cytokine antibody. Representative
plots are shown.
(D) Total numbers of cytokine producing TEa cells from each strain is shown. Data have been pooled from three independent experiments (ns, not significant;
*p < 0.05). See also Figure S2.
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Th17 cells.
We repeated these experiments in muLangerin-DTR mice that
lack both LCs and Langerin+ dDCs (Table 1). As in the Batf3/
mice, TEa cells in muLangerin-DTR mice showed normal prolif-
eration and a near-complete absence of IFN-g-producing cells
(Figures 7E and 7F and Figure S6B). Unexpectedly, the absenceof both LCs and Langerin+ dDCs resulted in normal numbers
of Th17 cells (Figure 7F), indicating that Langerin- dDCs were
sufficient for Th17 cell induction. Interestingly, the cytokines
expressed by Langerin- dDCs were similar to LCs (Figure 7B
and Figure S5B). Thus, like LCs, Langerin- dDCs can promote
Th17 cell differentiation but only in the absence of inhibition
from Langerin+ dDCs.Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc. 265
Figure 5. Direct Antigen Presentation by LCs Is
Required for Th17 Cell Development
As in Figure 4, TEa cells were adoptively transferred
into WT and huLangerin-Cre 3 I-Ab-flox mice prior to
skin infection.
(A) The expansion of TEa cells in Calb-WT (neg) in-
fected WT mice Calb-Ag infected WT and huLangerin-
Cre 3 I-Ab-flox is shown. Each symbol represents an
individual animal.
(B) Total numbers of cytokine producing TEa cells from
each strain is shown. Data have been pooled from two
independent experiments (ns, not significant; *p <
0.05).
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lated with functional outcome, we next examined whether
exaggerated Th17 and reduced Th1 cell responses in Batf3/
mice affected rechallenge with C. albicans. To this end, we chal-
lenged naive and previously infected WT and Batf3/ mice by
intradermal injection of 5 3 106 C. albicans blastoconidia. Three
days later, the skin was harvested and colony forming units
(CFU) determined. As expected, WT mice harbored significantly
fewer C. albicans than naive (‘‘Neg’’) mice (Figure 7G). Impor-
tantly, the number of CFU in Batf3/ mice was reduced by
20-fold compared to WT. Thus, the Th cell skewing observed
in Batf3/ mice in response to skin infection with C. albicans
was associated with an increased resistance to C. albicans
infection.
DISCUSSION
Herein, we have demonstrated that LCs are neither necessary
nor sufficient for cross-presentation of C. albicans antigen to
CD8+ CTLs in vivo. Instead, dermal Langerin+ DCs were required
for efficient cross-presentation. We also found that LCs were
necessary and sufficient for the development of Th17 cell
responses. In contrast, Langerin+ dDCs were required for the
generation of Th1 cell responses. Moreover, the absence of
Langerin+ dDC enhanced Th17 cell responses, suggesting that
these cells also inhibited the development of Th17 cells. Thus,
skin-resident DC subsets have specific, nonredundant functions
and promote distinct and opposing antigen-specific responses
in vivo.
By examining C. albicans-infected mice in which antigen
cannot be presented by LCs or can be presented only by LCs,
we have demonstrated that LCs are necessary and sufficient
for Th17 cell development. We observed that in response to
infection with C. albicans or S. aureus, LC produced elevated
amounts of IL-6, IL-1b, and IL-23, which both promote and stabi-
lize Th17 cell differentiation (Korn et al., 2009). Thus, we propose
that presentation of cutaneous antigen to naive CD4+ T cells in
the presence of these cytokines is responsible for the ability of
LCs to promote Th17 cells, and such a finding is consistent
with in vitro data (Aliahmadi et al., 2009; Mathers et al., 2009).
Activated LCs expressed low amounts of IL-27 and do not
express IL-12; IL-27 and IL-12 are both key cytokines for Th1
cell differentiation (Szabo et al., 2003). In addition, C. albicans-
infected Langerin-DTA mice had an intact Th1 cell response,
which suggested that LCs did not participate in Th1 cell develop-
ment. Batf3/ mice lack Langerin+ dDCs and did not develop266 Immunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc.Th1 cells. Langerin+ dDC expressed higher amounts of IL-12
and IL-27 than LCs, which probably explains the requirement
of this DC subset for Th1 cell development. Langerin+ dDCs
also had lower IL-1b and IL-6 expression as well as the absence
of IL-23, whichmakes thempoor promoters of Th17 cell differen-
tiation. Interestingly, IL-12 and IL-27 as well as IFN-g from Th1
cells have all been reported to inhibit Th17 cell formation and
proliferation (McGeachy and Cua, 2008; Stumhofer et al.,
2006; Stumhofer et al., 2010). The absence of these inhibitory
cytokines in Batf3/mice is likely to explain the observed exag-
gerated Th17 cell responses. Thus, presentation of the same
antigen by LCs and Langerin+ dDCs promotes opposing effects
that together allowed for the development of both Th1 cell and
appropriately balanced Th17 cell responses.
Cross-presentation by LCs has been clearly demonstrated
with cells derived in vitro from human bone marrow precursors
or isolated ex vivo from human skin explants when cultured with
soluble antigen in vitro (Klechevsky et al., 2008). LCs isolated
ex vivo from murine skin behave similarly (Flacher et al., 2010;
Stoitzner et al., 2006). In contrast, LCs isolated ex vivo from
LNs of mice in which antigen is only available to LCs in vivo either
during steady-state or via herpes virus infection cannot cross-
present antigen (Bedoui et al., 2009; Henri et al., 2010). Our
data from C. albicans-infected mice clearly demonstrate that
LCs are not necessary for cross-presentation. Similarly, presen-
tation by LCs was not sufficient to activate OT-I when antigen
was selectively targeted to LCs with anti-huLangerin-Ag
complexes. Thus, it appears that in vivo, LCs do not have the
capacity for cross-presentation. The ability of LCs isolated from
skin to cross-present in vitro may be specific to LCs while in the
epidermis or could be acquired during in vitro culture. Our
experiments with Batf3/ and muLangerin-DTR mice demon-
strated that Langerin+ dDCs were required for efficient cross-
presentation of skin-derived antigen. This is consistent with the
data examining DC populations in vivo (Wang et al., 2008) and
those isolated from LN ex vivo (Bedoui et al., 2009; Henri et al.,
2010). Targeting antigen to LCs in vivo with muLangerin anti-
bodies (clone L31) has been reported to result in efficient
cross-presentation (Idoyaga et al., 2008). Given that both
Langerin+ dDCs and LCs express muLangerin, we suggest that
Langerin+ dDCs, not LCs, are responsible for the observed effect.
Throughout this report, we have divided DCs into LCs,
Langerin+ dDCs, and Langerin- dDCs for the sake of expediency.
Although the first two are well defined and can be manipulated
in vivo, Langerin dDCs represent a heterogeneous population
that include ‘‘classic’’ CD11b+ dDCs as well as a more recently
Figure 6. Antigen Presentation by LCs Is Sufficient for Th17 Cell Development
(A) WT (shaded) and huLangerin-DTR (solid line) mice were injected i.p. with 10 mg anti-huLangerin (2G3) conjugated to Alexa-647. The amount of Alexa-647 16 hr
after injection is shown in epidermal cells gated on LCs (CD45+, MHC-II+), keratinocytes (KC; CD45-, MHC-II-), and dendritic epidermal T cells (DETC; CD45+,
MHC-II).
(B) As in (A) except that LCs isolated from the epidermis were identified by expression of endogenous mouse Langerin (green). The cellular location of 2G3-Alexa-
647 (red) and colocalization with muLangerin (yellow) was visualized by immunofluorescence.
(C) As in (A), cells were isolated from skin-draining LNs. The amount of 2G3-Alexa647 on LC (MHC-IIhi, CD11c+, CD8, Langerin+, CD103), Langerin+ dDCs
(MHC-IIhi, CD11c+, CD8-, Langerin+, CD103+), and Langerin dDCs (MHC-IIhi, CD11c+, CD8-, Langerin) is shown.
(D) WT or huLangerin-DTR mice were adoptively transferred with 33 105 naive OT-I cells 24 hr prior to i.p. injection of 1.0 ug 2G3-OVA257-264 or isotype control
(neg). Mice were then infected with Calb-WT on their skin. As a positive control, WTmice were immunized with 20 mg 2G3-OVA257-264 in CFA (pos). Skin-draining
LNs were harvested on day +4 and the total number of OT-I cells is shown.
(E) As in (D), except that TEa cells were transferred and mice were immunized with 2G3-Ea.
(F) CFSE and expression of IL-17A from TEa isolated fromWT and huLangerin-DTRmice infectedwithCalb-WT orS. aureus are shown. Data are representative of
three individual experiments. See also Figures S3 and S4.
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Figure 7. Langerin+ dDCs Promote Th1 and Inhibit Th17 Cell Differentiation
(A) LCs were sorted by flow cytometry on day +4 from skin-draining LNs from sham (open bars) or Calb-WT-infected (black bars) muLangerin-EGFP reporter
mice. Relative expression of mRNA of the indicated cytokines are shown.
(B) LCs (open bars), Langerin+ dDCs (black bars), and Langerin dDCs (gray bars) were sorted by flow cytometry fromCalb-WT-infectedmuLangerin-EGFPmice.
Relative expression of mRNA of the indicated cytokines are shown.
(C and D) As in Figure 4, WT (open bars) and Batf3/ (black bars) mice were infected with Calb-Ag. Proliferation (C) and cytokine expression (D) are shown.
(E and F) As in (C), except that muLangerin-DTR mice that had been injected with DT (black bars) or PBS (open bars) were used. Data are representative of three
individual experiments.
(G) Cohorts of four to eight WT and Batf3/mice were skin infected with Calb-WT or sham (‘‘Neg’’). Mice were then reinfected by intradermal injection of 53 106
Calb-WT on day +9. Three days later, skin was harvested and CFU obtained. (*p < 0.05). Data are pooled from two independent experiments. See also Figures S5
and S6. n.d., not detected.
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these DCs has been poorly explored, though, intriguingly,
CD103 dDCs have the unique ability to express retinoic acid
and may be important for the generation of Treg cell during
steady state (Guilliams et al., 2010). We cannot directly manipu-
late these Langerin dermal DC subsets with our present tools,
but they are the only skin-resident subset that remains in DT-
treated muLangerin-DTR mice. In the absence of LCs and
Langerin+ dDCs, we observed a modest amount of cross-
presentation of C. albicans-derived antigen. Thus, at least one
of the subsets contained within the Langerin dDC population
has the capacity for cross-presentation. Moreover, this popula-
tion has a cytokine profile similar to LCs (high IL1b, IL-6, and
IL-23 and low IL-12 and IL-27) and is sufficient to promote
Th17 cell differentiation when inhibition from Langerin+ dDCs is
absent (Figure 7). Recently, yet another DC subset derived
from monocytes in response to LPS via TLR4 stimulation has
been reported (Cheong et al., 2010). Although LPS is absent
from our system, we cannot exclude that a similar inflamma-
tory-type DC was present within the Langerin dDC subset.
In conclusion, we have demonstrated in vivo, that skin-resi-
dent DC subsets can promote unique and opposite T cell
responses directed against the same antigen. This has important
implications for vaccination strategies that selectively target DC
populations (Palucka et al., 2010). In addition, the requirement
for LCs in the development of Th17 cells suggests these cells
may participate in the early pathogenesis of Th17 cell-mediated
skin diseases such as psoriasis. At present, we have explored
the response to C. albicans and S. aureus, which both promote
Th17 cell-type responses. An important question for future
investigation is whether Langerin+ dDCs and LCs also promote
opposite T cell responses during the steady state and in
response to pathogens or adjuvants that do not induce Th17
cell-type responses.
EXPERIMENTAL PROCEDURES
Mice
HuLangerin-DTA (Kaplan et al., 2005), huLangerin-Cre I-Ab-flox (Igyarto et al.,
2009), huLangerin-DTR (Bobr et al., 2010), muLangerin-DTR (Kissenpfennig
et al., 2005), and muLangerin-EGFP (Kissenpfennig et al., 2005) mice have
been previously described. Batf3/ mice (Hildner et al., 2008) that had been
backcrossed ten generations onto the C57BL/6 background were a generous
gift from K. Murphy (Washington University, St Louis, MO). B6 Rag-1/ mice
were purchased from The Jackson Laboratory (Bar Harbor, ME). OT-I.PL Cd8
T cell receptor (TCR) transgenic specific for OVA257-264 (Hogquist et al., 1994),
OT-II Rag1/ Cd4 TCR transgenic recognizing OVA323-339 (Barnden et al.,
1998), and TEa Rag1/ Cd4 TCR-transgenic to I-Ea50-66 (Grubin et al.,
1997) mice on CD90.1 C57BL/6 backgrounds were also used. All experiments
were performed with 6- to 10-week-old and sex-matched mice. Mice were
housed in microisolator cages and fed irradiated food and acidified water.
The University of Minnesota institutional care and use committee approved
all mouse protocols.
DC Depletion with Diphtheria Toxin
MuLangerin-DTR mice were i.p. injected with 1 mg of diphtheria toxin (List
Biological Laboratories, Campbell, CA) 2 days before infection, as previously
described (Bobr et al., 2010; Kissenpfennig et al., 2005).
Antibodies
Fluorochrome-conjugated antibodies to CD4, CD8, CD11b, CD11c, CD90.1,
CD103, MHC class II, IFN-g, and IL-17A were purchased from Biolegend(San Diego, CA). Anti-mouse Langerin (L31), IL-17F, and IL-22 were acquired
from eBioscience (San Diego, CA).
Adoptive T Cell Transfer
Skin-draining lymph nodes and mesenteric lymph node of OT-II and TEamice
were disrupted through a cell strainer and washed with sterile HBSS. Naive
(CD44low) OT-I T cells were purified from lymph nodes of OT-I.PL mice as
described (Bursch et al., 2009). Cell purity (>95%) was determined by flow
cytometry before adoptive transfer. The cells were labeled with CFSE (Invitro-
gen, Carlsbad, CA) in accordance with the manufacturer’s instructions and
resuspended in sterile PBS at a concentration of 1 3 106 cell/ml. Three
hundred ml (3 3 105) cells were injected intravenously. Transferred cells were
detected in recipient mice based on expression of congenic CD90.1.
Flow Cytometry
Single-cell lymph node suspensions were obtained and stained as previously
described (Kaplan et al., 2005). For evaluating cytokine expression, cells were
incubated for 5 hr in complete RPMI 1640 supplemented with PMA (50 ng/ml)
and ionomycin (1.5 mM; Sigma-Aldrich, St. Louis, MO), with GolgiStop
(BD PharMingen, San Jose, CA) added for the final 4 hr. The intracellular cyto-
kine staining was performed with BD Bioscience Cytofix/Cytoperm kit (BD
Biosciences, San Jose, CA) in accordance with the manufacturer’s instruc-
tions. Samples were analyzed on LSR-II flow cytometers (BD Biosciences).
Detection of 2W1S specific CD4 T cells was performed as published with an
I-Ab-2W1S tetramer (a kind gift of M. Jenkins) (Moon et al., 2007). Data were
analyzed with FlowJo software (TreeStar, Ashland, OR). Isolation of DC
subsets by flow cytometric cell sorting and analysis of mRNA expression is
described in Supplemental Experimental Procedures.
Skin Infection Model
Mice were first anesthetized with a mixture of ketamine and xylazine
(100/10 mg/kg body weight), shaved on the back with electric clipper, and
chemically depilated with Nair hair remover (Church & Dwight, Princeton,
NJ) per the manufacturer’s instructions. The stratum corneum was removed
with 15 strokes with 220 grit sandpaper (3M, St Paul, MN). C. albicans (WT or
recombinant) was grown in YPAD medium (Sherman, 1991) at 30C until the
OD600 reached 1.5–2.0. After washing with sterile PBS, 2 3 10
8 C. albicans
in 50 ml of sterile PBS was applied on to the skin. In some experiments,
Staphylococcus aureus (ALC2906) grown in LB media was applied onto
shaved mouse skin at a concentration of 2 3 108 bacteria in 50 ml of PBS.
Delayed-Type Hypersensitivity
Eight days after skin infection, mice were challenged with footpad injection of
107 heat killed (60C for an hour) Candida albicans yeast cells. The specific
DTH was determined on the basis of the degree of footpad swelling 24 hr after
challenge in infected mice subtracted by the degree of swelling in sham
infected control mice.
Mouse Skin CFU
The mice infected with Candida albicans were sacrificed prior to infection and
on day 2, 4, 5, and 7 after infection. The infected area was cleansed with
povidone-iodine, which was removed once dry, and a 2.0 cm2 section of
skin was homogenized in sterile PBS containing penicillin and streptomycin
prior to plating on YPAD plates. In some experiments, previously infected
mice were rechallenged by intradermal injection of 5 3 106 C. albicans. Three
days later, 1.0 cm2 of skin surrounding the injection site was harvested and
homogenized in sterile PBS containing penicillin and streptomycin prior to
plating on YPAD plates. Colony counts were obtained 24–48 hr later.
Construction of Recombinant C. albicans
All Candida albicans strains used in this study were derived from SC5314
(Calb-WT) (Fonzi and Irwin, 1993). Construction of recombination vectors
and generation of recombinant C. albicans is described in the Supplemental
Experimental Procedures.
In Vitro T Cell Stimulation
OT-I and OT-II cells were labeled with CFSE and used as responders. For
stimulators, Rag1/ CD90.1 spleen cells were harvested and irradiated withImmunity 35, 260–272, August 26, 2011 ª2011 Elsevier Inc. 269
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with 2 3 105 stimulators in 200 ml complete RPMI 1640 in CO2 incubator for
3 days supplemented with 105 heat killed Calb-WT or Calb-Ag yeast. Cells
were harvested and analyzed by flow cytometry.
Monoclonal Antibody Generation
The anti-human Langerin 2G3 hybridoma (ATCC PTA 9853) was derived from
mice immunized with human Langerin ectodomain fused to human IgFc as
previously described (Klechevsky et al., 2010; Ni et al., 2010). Recombinant
antibody fusion protein production is described in supplementary methods.
LC Targeting with Anti-huLangerin
WT and huLangerin-DTR mice were injected with 10 mg of 2G3-AL647. The
mice were sacrificed 16 hr later and the presence of the AL647 signal was
analyzed in epidermal and lymph node cells by flow cytometry as described
(Kaplan et al., 2005). In separate experiments, 3 3 105 TEa or OT-I cells
were transferred into WT and huLangerin-DTR mice. A day later, the mice
were immunized by intraperitoneal injection of 1.0 mg of 2G3-Ea, 2G3-
OVA257-264 or 2G3-2W1S in 100 ml of sterile PBS. Six hours later, the mice
were infected with Calb-WT on the dorsal skin. The skin draining lymph nodes
were harvested 4 days later and analyzed by flow cytometry.
Immunofluorescence Staining
Immunofluorescence was performed as previously described (Kaplan et al.,
2005). Images were captured with a microscope (DM5500; Leica) with digital
system and LAS AF software (version 1.5.1).
Histology
Skin samples were fixed overnight in 10% formalin, dehydrated, and
embedded in paraffin. The 7 mm microtome sections were stained with Peri-
odic Acid-Schiff stain in accordance with the manufacturer’s instructions
(Sigma-Aldrich).
Statistics
Significant differences were calculated with the Student’s unpaired, two-tailed
t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and two tables and can be found with this article online at
doi:10.1016/j.immuni.2011.06.005.
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